IGF-2
Selected indexed studies
- IGF-2 Preprograms Maturing Macrophages to Acquire Oxidative Phosphorylation-Dependent Anti-inflammatory Properties. (Cell Metab, 2019) [PMID:30745181]
- Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy. (J Clin Invest, 2024) [PMID:39545420]
- IGF2: Development, Genetic and Epigenetic Abnormalities. (Cells, 2022) [PMID:35741015]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- IGF-2 Preprograms Maturing Macrophages to Acquire Oxidative Phosphorylation-Dependent Anti-inflammatory Properties. (2019) pubmed
- Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy. (2024) pubmed
- IGF2: Development, Genetic and Epigenetic Abnormalities. (2022) pubmed
- Association of IGF-1 and IGF-2 genotypes with respiratory muscle strength in individuals with COPD: A cross-sectional study. (2024) pubmed
- Targeted proteomics of serum IGF-I, -II, IGFBP-2, -3, -4, -5, -6 and ALS. (2025) pubmed
- Persistent epigenetic differences associated with prenatal exposure to famine in humans. (2008) pubmed
- High glucose increases IGF-2/H19 expression by changing DNA methylation in HTR8/SVneo trophoblast cells. (2022) pubmed
- Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma. (2021) pubmed
- The Diagnostic Value of IGF-2 and the IGF/IGFBP-3 System in Silver-Russell Syndrome. (2017) pubmed
- Could serum IGF-1 and IGF-2 serve as potential biomarkers in idiopathic Parkinson's disease? A correlation with disease stages. (2025) pubmed